Inventor · disambiguated record
Jacob Bradley Schwarz
Also filed as: SCHWARZ JACOB · SCHWARZ JACOB B · SCHWARZ JACOB BRADLEY
33 granted patents·19 pending applications·154 citations·filing 2002–2024
96Inventor score
Files withARRAY BIOPHARMA INC8RAPT THERAPEUTICS INC8RQX PHARMACEUTICALS INC6WARNER LAMBERT CO6GENENTECH INC5
Top patents by PatentIndex Score
52 records- 0195US6642398B2Mono-and disubstituted 3-propyl gamma-aminobutyric acidsWARNER LAMBERT CO·Filed 2002·Granted Nov 4, 2003·45 cites·28 claims
- 0294US10683280B2Chemokine receptor modulators and uses thereofRAPT THERAPEUTICS INC·Filed 2019·Granted Jun 16, 2020·8 cites·22 claims
- 0393US11384064B2Chemokine receptor modulators and uses thereofRAPT THERAPEUTICS INC·Filed 2020·Granted Jul 12, 2022·3 cites·28 claims
- 0493US8697715B2Serine/threonine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2013·Granted Apr 15, 2014·21 cites·25 claims
- 0592US11192879B2Chemokine receptor modulators and uses thereofRAPT THERAPEUTICS INC·Filed 2020·Granted Dec 7, 2021·3 cites·28 claims
- 0687US2024051917A1Heterocyclic sulfonamides, uses and pharmaceutical compositions thereofBIOGEN MA INC·Filed 2023·Application pending·0 cites
- 0785US9763942B2Serine/threonine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2016·Granted Sep 19, 2017·5 cites·18 claims
- 0885US9259470B2Serine/threonine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2014·Granted Feb 16, 2016·6 cites·45 claims
- 0983US9708290B2Serine/threonine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2016·Granted Jul 18, 2017·3 cites·12 claims
- 1083US2025059167A1Chemokine receptor modulators and uses thereofRAPT THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1182US10154995B2Serine/threonine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Dec 18, 2018·3 cites·18 claims
- 1282US7160856B2α-O-linked glycoconjugates, methods of preparation and uses thereofSLOAN KETTERING INST CANCER·Filed 2002·Granted Jan 9, 2007·17 cites·47 claims
- 1381US11046699B2Pyrazolo-pyrimidin-amino-cycloalkyl compounds and their therapeutic usesRAPT THERAPEUTICS INC·Filed 2019·Granted Jun 29, 2021·3 cites·46 claims
- 1481US9670208B2Serine/threonine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2016·Granted Jun 6, 2017·4 cites·19 claims
- 1580US9388171B2Serine/threonine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2013·Granted Jul 12, 2016·6 cites·2 claims
- 1680US9187462B2Substituted quinazolines as serine/threonine kinase inhibitorsBLAKE JAMES F·Filed 2012·Granted Nov 17, 2015·6 cites·21 claims
- 1780US9133187B2Serine/threonine kinase inhibitorsBLAKE JAMES F·Filed 2012·Granted Sep 15, 2015·6 cites·20 claims
- 1878US11084829B2Ubiquitin-specific-processing protease 7 (USP7) modulators and uses thereofRAPT THERAPEUTICS INC·Filed 2019·Granted Aug 10, 2021·2 cites·55 claims
- 1977US12098139B2Chemokine receptor modulators and uses thereofRAPT THERAPEUTICS INC·Filed 2022·Granted Sep 24, 2024·0 cites·24 claims
- 2073US10722514B2Ubiquitin-specific-processing protease 7 (USP7) modulators and uses thereofFLX BIO INC·Filed 2018·Granted Jul 28, 2020·2 cites·33 claims
- 2173US10392422B2Macrocyclic broad spectrum antibioticsRQX PHARMACEUTICALS INC·Filed 2015·Granted Aug 27, 2019·2 cites·19 claims
- 2271US7064147B2Amino acids with affinity for the α-2-delta-proteinWARNER LAMBERT CO·Filed 2003·Granted Jun 20, 2006·4 cites·8 claims
- 2368US2023133817A1Macrocyclic broad spectrum antibioticsRQX PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2468US2023133667A1Macrocyclic broad spectrum antibioticsRQX PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2567US2019100491A1Heterocyclic sulfonamides, uses and pharmaceutical compositions thereofBIOGEN MA INC·Filed 2018·Application pending·0 cites
- 2664US7250433B2Tetrazole and oxadiazolone substituted β-amino acid derivativesWARNER LAMBERT CO·Filed 2004·Granted Jul 31, 2007·4 cites·7 claims
- 2763US7030267B2Cycloproply β-amino acid derivativesWARNER LAMBERT CO·Filed 2004·Granted Apr 18, 2006·1 cites·3 claims
- 2863US2014323502A1Heterocyclic sulfonamides, uses and pharmaceutical compositions thereofPFIZER·Filed 2014·Application pending·0 cites
- 2962US2017247360A1Heterocyclic sulfonamides, uses and pharmaceutical compositions thereofPFIZER·Filed 2017·Application pending·0 cites
- 3060US2016272625A1Heterocyclic sulfonamides, uses and pharmaceutical compositions thereofPFIZER·Filed 2016·Application pending·0 cites
- 3158US11427558B1Indazoles and azaindazoles as LRRK2 inhibitorsESCAPE BIO INC·Filed 2020·Granted Aug 30, 2022·0 cites·18 claims
- 3258US10519126B2Serine/threonine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Dec 31, 2019·0 cites·4 claims
- 3356US10647731B2Thiazolopyrimidinones and methods of use thereofGENENTECH INC·Filed 2018·Granted May 12, 2020·0 cites·70 claims
- 3456US8686043B2Heterocyclic sulfonamides, uses and pharmaceutical compositions thereofFLIRI ANTON FRANZ JOSEPH·Filed 2012·Granted Apr 1, 2014·0 cites·18 claims
- 3555US2023077268A1Indazoles and azaindazoles as lrrk2 inhibitorsESCAPE BIO INC·Filed 2022·Application pending·0 cites
- 3654US2021198316A9Macrocyclic broad spectrum antibioticsRQX PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 3753US2005272783A1Amino acids with affinity for the alpha2delta-proteinBARTA NANCY SUE·Filed 2005·Application pending·0 cites
- 3852US8278457B2Heterocyclic sulfonamides, uses and pharmaceutical compositions thereofFLIRI ANTON F J·Filed 2010·Granted Oct 2, 2012·0 cites·4 claims
- 3952US2018327367A1Macrocyclic broad spectrum antibioticsRQX PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 4051US2009197859A1Pyridinyl Amides for the Treatment of CNS and Metabolic DisordersPFIZER·Filed 2009·Application pending·0 cites
- 4150US7388023B2Amino acids with affinity for the α2δ-proteinWARNER LAMBERT CO·Filed 2006·Granted Jun 17, 2008·0 cites·16 claims
- 4250US2011172297A1Oxopiperdinyl And Pyranyl Sulfonamides and Pharmaceutical Compositions ThereofPFIZER·Filed 2009·Application pending·0 cites
- 4349US7179934B2Amino acids with affinity for the α2δ-proteinWARNER LAMBERT CO·Filed 2004·Granted Feb 20, 2007·0 cites·2 claims
- 4448US2021317134A1Ubiquitin-specific-processing protease 7 (usp7) modulators and uses thereofRAPT THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4545US12071425B2Phenoxy-pyridyl-pyrimidine compounds and methods of useGENENTECH INC·Filed 2019·Granted Aug 27, 2024·0 cites·26 claims
- 4645US2004102607A1Trimeric antigenic O-linked glycopeptide conjugates, methods of preparation and uses thereofFiled 2003·Application pending·0 cites
- 4744US9988400B2Thiazolopyrimidinones and methods of use thereofGENENTECH INC·Filed 2016·Granted Jun 5, 2018·0 cites·70 claims
- 4844US2004063789A1Mono-and disubstituted 3-propyl gamma-aminobutyric acidsFiled 2003·Application pending·0 cites
- 4944US2022048888A1Pyrimidinyl-heteroaryloxy-naphthyl compounds and methods of useGENENTECH INC·Filed 2019·Application pending·0 cites
- 5043US10968203B2Pyrimidinyl-pyridyloxy-naphthyl compounds and methods of treating IRE1-related diseases and disordersGENENTECH INC·Filed 2018·Granted Apr 6, 2021·0 cites·41 claims
Showing the top 50 of 52 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Jacob Bradley Schwarz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →